Australia markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.55-0.03 (-0.40%)
At close: 04:00PM EDT
7.61 +0.06 (+0.79%)
After hours: 05:18PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts77108
Avg. Estimate-0.14-0.15-0.59-0.65
Low estimate-0.21-0.22-0.88-0.97
High estimate-0.11-0.12-0.43-0.43
Year ago EPS0.54-0.020.5-0.59
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts77108
Avg. Estimate12.24M12.92M51.94M65.87M
Low estimate7M7M25M38M
High estimate19.3M20.9M86.8M82.43M
Year ago sales316.58M45.92M485.42M51.94M
Sales growth (year/est)-96.10%-71.90%-89.30%26.80%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS0.38-0.020.040
Actual EPS0.54-0.020.08-0.1
Difference0.1600.04-0.1
Surprise %42.10%0.00%100.00%N/A
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.14-0.15-0.59-0.65
7 days ago-0.14-0.15-0.59-0.65
30 days ago-0.14-0.15-0.59-0.66
60 days ago-0.14-0.14-0.45-0.55
90 days ago-0.12-0.13-0.44-0.55
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesABCLIndustrySector(s)S&P 500
Current qtr.-125.90%N/AN/AN/A
Next qtr.-650.00%N/AN/AN/A
Current year-218.00%N/AN/AN/A
Next year-10.20%N/AN/AN/A
Next 5 years (per annum)10.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A